Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00412360 · ClinicalTrials.gov registry record · Phase 3
Single vs Double Umbilical Cord Blood Transplants in Children With High Risk Leukemia and Myelodysplasia (BMT CTN 0501)
A Phase 3 study, sponsored by Medical College of Wisconsin.
- Completed
- Registry status
- Phase 3
- Development phase
- 224
- Enrollment target
NCT00412360 is a Phase 3 study that has completed, run by Medical College of Wisconsin. The registered enrollment target is 224 participants.
The verdict
NCT00412360, a Phase 3 study, has completed, sponsored by Medical College of Wisconsin.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 224 participants
- Enrollment target
Study Summary
This study is a Phase III, randomized, open-label, multi-center, prospective study of single umbilical cord blood (UCB) transplantation versus double UCB transplantation in pediatric patients with hematologic malignancies.
Interventions
- DRUG Cyclophosphamide
- DRUG Fludarabine
- RADIATION Total Body Irradiation
- BIOLOGICAL Single Umbilical Cord Blood Unit Transplant
- BIOLOGICAL Double Umbilical Cord Blood Unit Transplant
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 224 participants |
| Start Date | 2006-12 |
| Est. Completion | 2014-10 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00412360
The ClinicalTrials.gov registry entry for NCT00412360 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 224 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical College of Wisconsin, which has 447 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Cyclophosphamide is the first listed.
NCT00412360 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00412360 about?
NCT00412360 is a clinical study titled "Single vs Double Umbilical Cord Blood Transplants in Children With High Risk Leukemia and Myelodysplasia (BMT CTN 0501)". This study is a Phase III, randomized, open-label, multi-center, prospective study of single umbilical cord blood (UCB) transplantation versus double UCB transplantation in pediatric patients with hematologic malignancies.
What is the current status of trial NCT00412360?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 224 participants. The study started on 2006-12. Estimated completion is 2014-10.
What interventions are being tested in trial NCT00412360?
The interventions under investigation include: Cyclophosphamide (DRUG), Fludarabine (DRUG), Total Body Irradiation (RADIATION), Single Umbilical Cord Blood Unit Transplant (BIOLOGICAL), Double Umbilical Cord Blood Unit Transplant (BIOLOGICAL).
Who is sponsoring clinical trial NCT00412360?
This trial is sponsored by Medical College of Wisconsin, which has 447 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.